Bios Capital Management, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Bios Capital Management, Lp disclosed 4 stock positions valued at approximately $41.67M as of quarter-end June 30, 2026. The largest holdings include OPUS GENETICS INC, COGNITION THERAPEUTICS INC, and REIN THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 4
- Portfolio Value
- $41.67M
Holdings by Sector
Bios Capital Management, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| OPUS GENETICS INC | OCUP | Other | 36.33% | 3,683,429 | - | - | $15,138,893 |
| COGNITION THERAPEUTICS INC | CGTX | Healthcare | 16.56% | 6,000,000 | - | - | $6,900,001 |
| REIN THERAPEUTICS INC | ALRN | Healthcare | 7.44% | 2,982,375 | +1,000,000 | +50.44% | $3,101,670 |
| LANTERN PHARMA INC | LTRN | Healthcare | 2.50% | 249,397 | -615,038 | -71.15% | $1,039,985 |
Showing 4 of 4 holdings in the latest reporting period.